BOCA RATON, FL, Jan. 8 /CNW/ - On December 24, 2008, the Rogers Family
Charitable Foundation, Inc. (the "Foundation") acquired ownership by way of
gift of an aggregate of 2,490,476 common shares of Bradmer Pharmaceuticals
Inc. (TSX:BMR) (the "Corporation"), representing approximately 18.5% of the
issued and outstanding common shares of the Corporation, from Baltimore
Biotech Holdings Inc., Bradmer Ventures Inc., Bigeminy LLLP, Dr. Mark Rogers
and Dr. Elizabeth Rogers (collectively, the "Transferors").
Following the gifting of the common shares, the Foundation held an
aggregate of 3,202,576 common shares representing approximately 23.7% of the
issued and outstanding common shares of the Corporation. None of the
Transferors exercises control or direction, directly or indirectly, over the
Foundation. The Foundation has no current future intention to acquire
additional common shares of the Corporation.
The Foundation will file an early warning report describing the above
transactions with applicable Canadian securities regulators, a copy of which
will be available under the Corporation's profile at www.SEDAR.com.
For further information:
For further information: Rogers Family Charitable Foundation, Inc., c/o
Morris Law Group, 7000 West Palmetto Park Road, Suite 205, Boca Raton,
Florida, 33433, Attention: Stuart R. Morris Esq., Chair of Directors,
Telephone: (561) 750-3850